Navigation Links
Encorium Reports Fourth Quarter and Full Year 2008 Financial Results
Date:4/27/2009

in direct expenses was partially affected by approximately $340,000 of favorable foreign currency fluctuations absorbed by the Company's European operations in the fourth quarter of 2008.

Selling, general, and administrative expenses (SG&A) increased slightly to $3.3 million, or 46.5% of net revenue, for the three months ended December 31, 2008, compared to $3.2 million, or 38.6% of net revenue, for the three months ended December 31, 2007.

Depreciation and amortization expense decreased by 72.8% to $203,077 for the three months ended December 31, 2008 from $745,375 for the three months ended December 31, 2007 primarily as a result of a reduction in the amount of amortization related to the intangible assets acquired from the Remedium acquisition.

The Company reported a net loss for the fourth quarter of 2008 of $13.7 million, or $(0.67) per diluted share. Included in the results is a non cash $12.5 million, or $(0.61) per share, impairment charge related to the Company's goodwill and certain of its intangible assets. This resulted from the second step of the Company's impairment analysis. The impairment was triggered by a number of factors, including the sustained decline in the Company's stock price during the third quarter of 2008 and the continued deterioration of the underlying comparable companies within the CRO industry as it related to the market value approach methodology. In the fourth quarter of 2007, the Company reported a net loss of $732,000, or $(0.04) per diluted share.

Dr. David Ginsberg, Encorium Group's Chief Executive Officer, commented, "We continue to work on differentiating the Company, pursuing new business as well as enhancing shareholder value."

2008 Full Year Financial Results

Net revenue for the twelve months ended December 31, 2008 decreased to $30.2 million as compared to $31.7 million for the twelve months ended De
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing
2. Encorium Appoints Shahab Fatheazam to its Board of Directors
3. Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share
4. Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 2009
5. Remuda Ranch Reports Eating Disorders on the Rise Among Elderly
6. HCA Reports First Quarter 2009 Results
7. Recent Study Disproves General Hospitals Ongoing Criticism of Physician Owned Hospitals, Shows Little to No Effect on General Hospitals Business, Reports Physician Hospitals of America
8. Neovasc Inc. Reports Year 2008 Financial Results
9. NBTY Reports Second Quarter Results
10. Statement from USPA Exec. Dir. on News Reports of Florida Pharmacy Admission of Error in the Medicine Dispensed to the Horses Who Died on Sunday
11. Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... that sudden, acute episodes of low back pain are ... air pressure, wind direction and precipitation. Findings published in ... the American College of Rheumatology (ACR), indicate that the ... wind speed or wind gusts, but was not clinically ... (WHO) nearly everyone experiences low back pain at some ...
(Date:7/9/2014)... all types of cancer sends the protein factories in ... tumour,s uncontrolled growth, new research suggests. , Scientists at ... trigger responsible for ratcheting up activity of the endoplasmic ... building blocks cancer cells need to keep growing. , ... controls the flow of messages to the endoplasmic reticulum ...
(Date:7/9/2014)... R.I. Researchers have found that fecal transplantation ... in immunocompromised patients. This is the result of ... in the Center for Women,s Gastrointestinal Medicine at The ... been published online in advance of print in the ... difficile , or C. diff , has increased ...
(Date:7/9/2014)... 2014 There has been a sharp increase in ... Center using MyChart, the online, interactive service that allows ... their healthcare providers, schedule appointments, and renew prescriptions. , ... using MyChart each year increased five-fold, while ... than 10-fold, according to a study by Dr. ...
(Date:7/9/2014)... National Institute of Allergy and Infectious Diseases (NIAID), ... launched an early-stage clinical trial of CRS3123, an ... difficile ( C. difficile ) infection. CRS3123 ... that inhibits C. difficile growth while sparing normal ... enroll up to 30 healthy men and women ...
Breaking Medicine News(10 mins):Health News:Low back pain? Don't blame the weather 2Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2
... the same protein that was a primary mediator of the birth ... multiple myeloma , says the study,s senior investigator, Keith ... Dr. Stewart presented the results at the 53rd annual meeting of ... The drug thalidomide achieved infamy in the early 1960s as the ...
... December 10, 2011) Symptoms improved significantly in adults ... treatment with gene therapy developed by researchers at St. ... be safe in a clinical trial conducted at the ... findings of the six-person study mark the first proof ...
... , FRIDAY, Dec. 9 (HealthDay News) -- Flu vaccination is ... protect your health during the flu season, but too few ... shrug off concerns about the flu, yet every year it ... 200,000 to the hospital and killing thousands," Dr. Thomas Slama, ...
... so many postmenopausal women who are treated for estrogen-sensitive ... disease from recurring? The first study to actually ... largest, most scientifically rigorous study to examine the question ... of the medications, side effects, which are more severe ...
... present in dangerous quantities in the Vauchre river basin ... be presented the 9th of December, at the American ... to kill microorganisms, called biocides, are added to exterior ... Washed off of building facades during heavy rains, however, ...
... 9 (HealthDay News) -- ,Preschool children who were born just ... behavioral and emotional problems, new research suggests. Researchers in ... development tests on about 1,500 children when they were 4 ... and nearly 1,000 were born between 32 and 35 weeks ...
Cached Medicine News:Health News:Mayo Clinic: How patients will respond to immunomodulator therapy for multiple myeloma 2Health News:Gene therapy achieves early success against hereditary bleeding disorder 2Health News:Gene therapy achieves early success against hereditary bleeding disorder 3Health News:Americans Encouraged to Get Flu Vaccine 2Health News:Why women quit breast cancer drugs early 2Health News:Why women quit breast cancer drugs early 3Health News:Model shows how façade pollutants make it into the environment 2Health News:Behavior Problems May Surface in Preemies by Preschool 2
(Date:1/15/2014)... , Jan. 15, 2014 As health officials across ... virus, select Meijer pharmacies in Michigan ... to eligible patients, enabling Meijer pharmacists to administer tests and, ... set by a physician participating in the study. ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health ... several new IT value-added reseller (VAR) national contracts that ... goods and services at lower costs. These include manufacturer ... such as initiative assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
... 2012  Pharmaceutical marketers who need to calibrate multi-channel marketing ... limitless questions. SyntheSight™ , a new ... with a patent-pending IntelliScore™ , provides ... leaders find answers. SyntheSight ...
... the fastest growing Electronic Medical Record ... its award winning e-prescribing software has been revamped; ... experience based on community feedback. The company,s free ... interactions for medical professionals in 2011 alone. ...
Cached Medicine Technology:RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite 2RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite 3Practice Fusion's Top-Rated e-Prescribing Software Gets a Doctor-Driven Makeover 2Practice Fusion's Top-Rated e-Prescribing Software Gets a Doctor-Driven Makeover 3
... ExTOL systems feature your choice of ... electrocardiographs, an easy-to-operate monitor and the ... exercise stress testing systems also feature ... point, pre-programmed or custom protocols, and ...
... w/ Remote/Controller. Includes Full Range ... Children. Multiple 20/20 slides. Polarized ... allows you to customize your slide choices. ... with Long Life. Variety of mounting options. ...
... Ultimate in Stability. ... stabilizer features superior arm ... in the clamp/turret mechanism. ... features the ultimate flexibility ...
... leader in beating heart bypass, comes the ... NS device is the first leap in ... of surgical revascularization.,The Starfish NS Heart Positioner ... Small Thoracotomy (MVST) procedure without CPB and ...
Medicine Products: